Table of Contents Author Guidelines Submit a Manuscript
PPAR Research
Volume 2016 (2016), Article ID 5465804, 12 pages
http://dx.doi.org/10.1155/2016/5465804
Research Article

IL-15 Mediates Mitochondrial Activity through a PPARδ-Dependent-PPARα-Independent Mechanism in Skeletal Muscle Cells

1Department of Health Science and Kinesiology, Crean College of Health and Behavioral Sciences, Chapman University, Orange, CA, USA
2Department of Biological Sciences, Human and Evolutionary Biology Section, Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, USA

Received 28 April 2016; Revised 1 August 2016; Accepted 21 August 2016

Academic Editor: Aihua Zhang

Copyright © 2016 Shantaé M. Thornton et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. L. Ogden, M. D. Carroll, B. K. Kit, and K. M. Flegal, “Prevalence of childhood and adult obesity in the United States, 2011-2012,” The Journal of the American Medical Association, vol. 311, no. 8, pp. 806–814, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. CDC and NCHS, Underlying Cause of Death 1999–2013, CDC Wonder Online Database, 2015.
  3. B. Egan and J. R. Zierath, “Exercise metabolism and the molecular regulation of skeletal muscle adaptation,” Cell Metabolism, vol. 17, no. 2, pp. 162–184, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. R. T. Hepple, “Mitochondrial involvement and impact in aging skeletal muscle,” Frontiers in Aging Neuroscience, vol. 6, article 211, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. A.-S. Arnold, A. Egger, and C. Handschin, “PGC-1α and myokines in the aging muscle—a mini-review,” Gerontology, vol. 57, no. 1, pp. 37–43, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Walsh, “Adipokines, Myokines and Cardiovascular Disease,” Circulation Journal, vol. 73, no. 1, pp. 13–18, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Eckardt, S. W. Görgens, S. Raschke, and J. Eckel, “Myokines in insulin resistance and type 2 diabetes,” Diabetologia, vol. 57, no. 6, pp. 1087–1099, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Raschke and J. Eckel, “Adipo-Myokines: two sides of the same coin—mediators of inflammation and mediators of exercise,” Mediators of Inflammation, vol. 2013, Article ID 320724, 16 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. B. K. Pedersen, “Muscle as a secretory organ,” in Comprehensive Physiology, John Wiley & Sons, New York, NY, USA, 2013. View at Publisher · View at Google Scholar
  10. B. K. Pedersen and M. A. Febbraio, “Muscles, exercise and obesity: skeletal muscle as a secretory organ,” Nature Reviews Endocrinology, vol. 8, no. 8, pp. 457–465, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C. T. Lutz and L. S. Quinn, “Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism,” Aging, vol. 4, no. 8, pp. 535–546, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. Argilés, F. J. López-Soriano, and S. Busquets, “Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposity,” Drug Discovery Today, vol. 14, no. 3-4, pp. 208–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Alvarez, N. Carbó, J. López-Soriano et al., “Effects of interleukin-15 (IL-15) on adipose tissue mass in rodent obesity models: evidence for direct IL-15 action on adipose tissue,” Biochimica et Biophysica Acta—General Subjects, vol. 1570, no. 1, pp. 33–37, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Sun and D. Liu, “Hydrodynamic delivery of interleukin 15 gene promotes resistance to high fat diet-induced obesity, fatty liver and improves glucose homeostasis,” Gene Therapy, vol. 22, no. 4, pp. 341–347, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. L. S. Quinn and B. G. Anderson, “Interleukin-15, IL-15 receptor-alpha, and obesity: concordance of laboratory animal and human genetic studies,” Journal of Obesity, vol. 2011, Article ID 456347, 8 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. E. F. Castillo and K. S. Schluns, “Regulating the immune system via IL-15 transpresentation,” Cytokine, vol. 59, no. 3, pp. 479–490, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. R. Gray and T. Kamolrat, “The effect of exercise induced cytokines on insulin stimulated glucose transport in C2C12 cells,” Cytokine, vol. 55, no. 2, pp. 221–228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Rinnov, C. Yfanti, S. Nielsen et al., “Endurance training enhances skeletal muscle interleukin-15 in human male subjects,” Endocrine, vol. 45, no. 2, pp. 271–278, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. D. Crane, L. G. Macneil, J. S. Lally et al., “Exercise-stimulated interleukin-15 is controlled by AMPK and regulates skin metabolism and aging,” Aging Cell, vol. 14, no. 4, pp. 625–634, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Catoire, M. Mensink, E. Kalkhoven, P. Schrauwen, and S. Kersten, “Identification of human exercise-induced myokines using secretome analysis,” Physiological Genomics, vol. 46, no. 7, pp. 256–267, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. J. R. Pierce, J. M. Maples, and R. C. Hickner, “Il-15 concentrations in skeletal muscle and subcutaneous adipose tissue in lean and obese humans: local effects of IL-15 on adipose tissue lipolysis,” American Journal of Physiology—Endocrinology and Metabolism, vol. 308, no. 12, pp. E1131–E1139, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Busquets, M. Figueras, V. Almendro, F. J. López-Soriano, and J. M. Argilés, “Interleukin-15 increases glucose uptake in skeletal muscle. An antidiabetogenic effect of the cytokine,” Biochimica et Biophysica Acta—General Subjects, vol. 1760, no. 11, pp. 1613–1617, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. K. M. Ajuwon and M. E. Spurlock, “Direct regulation of lipolysis by interleukin-15 in primary pig adipocytes,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 287, no. 3, pp. R608–R611, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Almendro, S. Busquets, E. Ametller et al., “Effects of interleukin-15 on lipid oxidation. Disposal of an oral [14C]-triolein load,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1761, no. 1, pp. 37–42, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. N. G. Barra, R. Palanivel, E. Denou et al., “Interleukin-15 modulates adipose tissue by altering mitochondrial mass and activity,” PLoS ONE, vol. 9, no. 12, Article ID e114799, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. G. C. O'Connell and E. E. Pistilli, “Interleukin-15 directly stimulates pro-oxidative gene expression in skeletal muscle in-vitro via a mechanism that requires interleukin-15 receptor alpha,” Biochemical and Biophysical Research Communications, vol. 458, no. 3, pp. 614–619, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. L. S. Quinn, B. G. Anderson, J. D. Conner, T. Wolden-Hanson, and T. J. Marcell, “IL-15 is required for postexercise induction of the pro-oxidative mediators PPARδ and SIRT1 in male mice,” Endocrinology, vol. 155, no. 1, pp. 143–155, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. L. S. Quinn, B. G. Anderson, J. D. Conner, and T. Wolden-Hanson, “IL-15 overexpression promotes endurance, oxidative energy metabolism, and muscle PPARδ SIRT1, PGC-1α and PGC-1β expression in male mice,” Endocrinology, vol. 154, no. 1, pp. 232–245, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Almendro, G. Fuster, S. Busquets et al., “Effects of IL-15 on rat brown adipose tissue: uncoupling proteins and PPARs,” Obesity, vol. 16, no. 2, pp. 285–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Fan and R. Evans, “PPARs and ERRs: molecular mediators of mitochondrial metabolism,” Current Opinion in Cell Biology, vol. 33, pp. 49–54, 2015. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Perez-Schindler and A. Philp, “Regulation of skeletal muscle mitochondrial function by nuclear receptors: implications for health and disease,” Clinical Science, vol. 129, no. 7, pp. 589–599, 2016. View at Publisher · View at Google Scholar · View at Scopus
  32. G. D. Barish, V. A. Narkar, and R. M. Evans, “PPARδ: a dagger in the heart of the metabolic syndrome,” The Journal of Clinical Investigation, vol. 116, no. 3, pp. 590–597, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. Y.-X. Wang, C.-H. Lee, S. Tiep et al., “Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity,” Cell, vol. 113, no. 2, pp. 159–170, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. K.-D. Wagner and N. Wagner, “Peroxisome proliferator-activated receptor beta/delta (PPARβ/δ) acts as regulator of metabolism linked to multiple cellular functions,” Pharmacology and Therapeutics, vol. 125, no. 3, pp. 423–435, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. Y.-X. Wang, C.-L. Zhang, R. T. Yu et al., “Regulation of muscle fiber type and running endurance by PPARδ,” PLoS Biology, vol. 2, no. 10, article e294, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. L. L. C. Poulsen, M. Siersbæk, and S. Mandrup, “PPARs: fatty acid sensors controlling metabolism,” Seminars in Cell and Developmental Biology, vol. 23, no. 6, pp. 631–639, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. A.-M. Krogsdam, C. A. F. Nielsen, S. Neve et al., “Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor δ-mediated transactivation,” Biochemical Journal, vol. 363, part 1, pp. 157–165, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Janani and B. D. Ranjitha Kumari, “PPAR gamma gene—a review,” Diabetes and Metabolic Syndrome: Clinical Research and Reviews, vol. 9, no. 1, pp. 46–50, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. J. M. Lehmann, L. B. Moore, T. A. Smith-Oliver, W. O. Wilkison, T. M. Willson, and S. A. Kliewer, “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ),” The Journal of Biological Chemistry, vol. 270, no. 22, pp. 12953–12956, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. M. J. Abbott, A. M. Edelman, and L. P. Turcotte, “CaMKK is an upstream signal of AMP-activated protein kinase in regulation of substrate metabolism in contracting skeletal muscle,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 297, no. 6, pp. R1724–R1732, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Wattanachanya, W.-D. Lu, R. K. Kundu et al., “Increased bone mass in mice lacking the adipokine apelin,” Endocrinology, vol. 154, no. 6, pp. 2069–2080, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. T. Tang, M. J. Abbott, M. Ahmadian, A. B. Lopes, Y. Wang, and H. S. Sul, “Desnutrin/ATGL activates PPARδ to promote mitochondrial function for insulin secretion in islet β cells,” Cell Metabolism, vol. 18, no. 6, pp. 883–895, 2013. View at Publisher · View at Google Scholar · View at Scopus
  43. M. J. Abbott, L. D. Bogachus, and L. P. Turcotte, “AMPKα2 deficiency uncovers time dependency in the regulation of contraction-induced palmitate and glucose uptake in mouse muscle,” Journal of Applied Physiology, vol. 111, no. 1, pp. 125–134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. M. J. Abbott and L. P. Turcotte, “AMPK-α2 is involved in exercise training-induced adaptations in insulinstimulated metabolism in skeletal muscle following high-fat diet,” Journal of Applied Physiology, vol. 117, no. 8, pp. 869–879, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. J. G. Giri, S. Kumaki, M. Ahdieh et al., “Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor,” The EMBO Journal, vol. 14, no. 15, pp. 3654–3663, 1995. View at Google Scholar · View at Scopus
  46. E. Dozio, A. E. Malavazos, E. Vianello et al., “Interleukin-15 and soluble interleukin-15 receptor α in coronary artery disease patients: association with epicardial fat and indices of adipose tissue distribution,” PLoS ONE, vol. 9, no. 3, article e90960, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. L. S. Quinn, B. G. Anderson, L. Strait-Bodey, A. M. Stroud, and J. M. Argilés, “Oversecretion of interleukin-15 from skeletal muscle reduces adiposity,” American Journal of Physiology—Endocrinology and Metabolism, vol. 296, no. 1, pp. E191–E202, 2008. View at Publisher · View at Google Scholar
  48. L. S. Quinn, B. G. Anderson, J. D. Conner, and T. Wolden-Hanson, “IL-15 overexpression promotes endurance, oxidative energy metabolism, and muscle PPARδ SIRT1, PGC-1α and PGC-1 β expression in male mice,” Endocrinology, vol. 154, no. 1, pp. 232–245, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Baar, “Involvement of PPARγ co-activator-1, nuclear respiratory factors 1 and 2, and PPARα in the adaptive response to endurance exercise,” Proceedings of the Nutrition Society, vol. 63, no. 2, pp. 269–273, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. D. M. Muoio and T. R. Koves, “Skeletal muscle adaptation to fatty acid depends on coordinated actions of the PPARs and PGC1α: implications for metabolic disease,” Applied Physiology, Nutrition and Metabolism, vol. 32, no. 5, pp. 874–883, 2007. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Handschin and B. M. Spiegelman, “Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy homeostasis, and metabolism,” Endocrine Reviews, vol. 27, no. 7, pp. 728–735, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Nakatani, N. Tsuboyama-Kasaoka, M. Takahashi, S. Miura, and O. Ezaki, “Mechanism for peroxisome proliferator-activated receptor-α activator-induced up-regulation of UCP2 mRNA in rodent hepatocytes,” Journal of Biological Chemistry, vol. 277, no. 11, pp. 9562–9569, 2002. View at Publisher · View at Google Scholar · View at Scopus
  53. S. J. Bensinger and P. Tontonoz, “Integration of metabolism and inflammation by lipid-activated nuclear receptors,” Nature, vol. 454, no. 7203, pp. 470–477, 2008. View at Publisher · View at Google Scholar · View at Scopus
  54. R. K. Semple, V. K. K. Chatterjee, and S. O'Rahilly, “PPARγ and human metabolic disease,” The Journal of Clinical Investigation, vol. 116, no. 3, pp. 581–589, 2006. View at Publisher · View at Google Scholar · View at Scopus